SequelSEC

FOXO TECHNOLOGIES INC. FOXO

Services-Commercial Physical & Biological Research · CIK 0001812360 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$17.86M
Fiscal year ended 2026-06-30
Operating income
-$877.76K
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$1.86MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.00Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.1×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.2×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Commercial Physical & Biological Research filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
R&D / revenue1.1%0th
Revenue YoY growth304.0%100th
SBC / revenue-1.0%0th
CapEx / revenue0.4%12th
Current ratio0.11x21th
FCF margin-24.0%75th
Net margin-75.9%64th
Operating margin-63.1%58th

FOXO TECHNOLOGIES INC. (FOXO) reported revenue of $17.86M and net income of -$4.60M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from FOXO TECHNOLOGIES INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Commercial Physical & Biological Research.

Income

FOXO TECHNOLOGIES INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$17.86M
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$877.76K
Net income-$4.60M
Research & development$171.56K
Weighted-average diluted sharesUnavailable
Pretax income-$4.80M
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$11.53M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

FOXO TECHNOLOGIES INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$58.41K
Total assets$45.89M
Current assets$4.76M
Total liabilities$44.98M
Current liabilities$40.62M
Total equity incl. NCI$913.22K
Temporary (mezzanine) equityUnavailable
Inventory$160.47K
Accounts receivable$4.14M
Goodwill$27.79M
Long-term debtUnavailable
Accounts payable$7.81M

Cash flow

FOXO TECHNOLOGIES INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$428.04K
Capital expendituresUnavailable
Investing cash flow-$650.08K
Financing cash flow$814.74K
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$654.50K

Derived

FOXO TECHNOLOGIES INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross marginUnavailable
Operating margin-4.9%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.12x
Revenue YoY growth44.0%
Net margin-25.8%
R&D / revenue1.0%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open FOXO in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q/A · Filed 2025-08-19View SEC filing
10-Q · Filed 2025-08-19View SEC filing

Companies in the same industry

ABSI BIAF BUDZ CBIH CRL IBAC INCY IQV ISPC MEDP MXCT NRC

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.